Recent advances and ongoing challenges in diabetes prevention and control in China - PubMed
4 hours ago
- #public health
- #diabetes
- #China
- Diabetes prevalence in China has increased from 2.5% in 1994 to 13.0% in 2021.
- The review covers type 1, type 2, youth-onset, and gestational diabetes, along with complications like macrovascular and microvascular issues, cancer, and dementia.
- Key risk factors include genetic susceptibility, obesity, diet, and physical activity, with differences noted between Chinese and Western populations.
- Advancements in diabetes management include national prevention efforts, innovative models, and new pharmacological therapies like GLP-1 receptor agonists and SGLT2 inhibitors.
- Challenges include underrepresentation of Chinese populations in research, regional disparities, gaps in primary healthcare, and technology integration in clinical practice.